UPDATED Jun 30, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CALTX | SEK 205.60 | 0.4% | 137.1% | SEK 11.0b | SEK 221.25 | PS8.4x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
A204620 | ₩3,650.00 | -5.8% | -6.9% | ₩207.3b | ₩7,100.00 | PS1.9x | E72.4% | n/a | Commercial Services | ||
HHR | AU$0.006 | -14.3% | -76.9% | AU$16.9m | n/a | PE5.7x | E86.3% | n/a | Energy | ||
688516 | CN¥41.81 | -11.0% | -54.9% | CN¥13.1b | CN¥95.32 | PE9.6x | E23.0% | 3.4% | Semiconductors | ||
CAI | AU$0.12 | 9.5% | -32.4% | AU$93.7m | n/a | PB0.7x | E107.7% | n/a | Materials | ||
300896 | CN¥172.10 | -2.8% | -45.9% | CN¥51.8b | CN¥315.14 | PE26.3x | E25.2% | 1.9% | Pharmaceuticals & Biotech | ||
A067310 | ₩20,500.00 | -7.2% | -6.2% | ₩972.2b | ₩31,666.67 | PB3.3x | E94.1% | 0.2% | Semiconductors | ||
SRPT | US$158.00 | -1.7% | 38.0% | US$14.9b | US$197.81 | PE883.9x | E39.4% | n/a | Pharmaceuticals & Biotech | ||
GTC | UK£0.03 | -6.2% | -68.4% | UK£2.1m | n/a | PB0.5x | E108.7% | 0% | Energy | ||
BCS | NOK 6.19 | 2.7% | -29.7% | NOK 259.8m | NOK 9.00 | PS863.1x | E50.7% | n/a | Materials | ||
SEAPT | NOK 2.74 | 42.7% | -71.8% | NOK 982.9m | NOK 11.57 | PB0.9x | E56.8% | n/a | Energy | ||
A101390 | ₩6,820.00 | -3.5% | -17.3% | ₩67.9b | n/a | PB3.1x | E106.3% | n/a | Tech | ||
300442 | CN¥23.95 | -8.6% | -22.1% | CN¥41.2b | CN¥38.05 | PE21.6x | E28.6% | 2.2% | Software | ||
2847 | CN¥42.77 | -8.0% | -29.6% | CN¥11.7b | CN¥67.44 | PE21x | E23.5% | 2.5% | Food, Beverage & Tobacco | ||
XBRANE | SEK 0.26 | -5.9% | -99.7% | SEK 402.3m | n/a | PS2.1x | E105.2% | n/a | Pharmaceuticals & Biotech | ||
EMH | €8.45 | 3.7% | -22.5% | €47.3m | €19.67 | PS2.4x | E75.4% | 1.2% | Consumer Services | ||
SILEON | SEK 0.56 | -6.7% | -87.9% | SEK 28.4m | n/a | PB1.8x | E109.3% | n/a | Software | ||
ACR | AU$0.069 | -5.5% | 64.3% | AU$20.1m | n/a | PS1.8x | E115.3% | 0% | Pharmaceuticals & Biotech | ||
CABP | UK£1.30 | -4.6% | n/a | UK£330.4m | UK£1.78 | PE14.4x | E30.5% | n/a | Diversified Financials | ||
300972 | CN¥21.13 | -0.6% | -52.3% | CN¥3.7b | CN¥28.61 | PB4.3x | E75.9% | 0% | Food, Beverage & Tobacco | ||
603800 | CN¥20.00 | -0.4% | -26.5% | CN¥4.1b | CN¥42.00 | PE18.8x | E33.5% | 0.7% | Energy | ||
FLNC | US$17.34 | -11.0% | -34.9% | US$3.1b | US$28.91 | PS1x | E100.7% | n/a | Capital Goods | ||
IVVD | US$1.10 | -11.3% | 4.8% | US$131.2m | US$9.23 | PB0.7x | E69.8% | n/a | Pharmaceuticals & Biotech | ||
GCT | US$30.42 | 3.7% | 350.0% | US$1.2b | US$52.33 | PE11.8x | E21.3% | n/a | Retail |